Showing results (201-210 of 224) with videos related to
Sort By:
Pageof 23
Journal of Cellular Biochemistry. Supplement|January 1, 1994
The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostatic adenocarcinoma in short-term phase II clinical trialsD G Bostwick, H B Burke, T M Wheeler, et al.European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|July 11, 2017
Bioactivity and prostate tissue distribution of metformin in a preprostatectomy prostate cancer cohortMike M Nguyen, Jessica A Martinez, Chiu-Hsieh Hsu, et al.American Journal of Translational Research|April 23, 2015
Combined micro CT and histopathology for evaluation of skeletal metastasis in live animalsChristopher P Geffre, Erika Pond, Gerald D Pond, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
Phase II study of erlotinib in patients with locally advanced or metastatic papillary histology renal cell cancer: SWOG S0317Michael S Gordon, Michael Hussey, Raymond B Nagle, et al.Journal of the National Cancer Institute|February 15, 1992
Coexpression of vimentin and keratins by human melanoma tumor cells: correlation with invasive and metastatic potentialM J Hendrix, E A Seftor, Y W Chu, et al.Cancer Prevention Research (Philadelphia, Pa.)|November 10, 2017
Does Mutated <i>K-RAS</i> Oncogene Attenuate the Effect of Sulindac in Colon Cancer Chemoprevention?Photini F S Rice, Kevin G Ehrichs, Mykella S Jones, et al.Cancer Biology & Therapy|November 16, 2006
Role of c-Myc in intestinal tumorigenesis of the ApcMin/+ mouseNatalia A Ignatenko, Hana Holubec, David G Besselsen, et al.The Prostate|May 9, 2013
ERG overexpression and PTEN status predict capsular penetration in prostate carcinomaRaymond B Nagle, Amit M Algotar, Connie C Cortez, et al.Biophysical Journal|September 28, 2023
Biophysical phenotype mixtures reveal advantages for tumor muscle invasion in vivoKendra D Marr, Jaime M C Gard, William L Harryman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2007
Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group StudyLinda L Garland, Cathryn Rankin, David R Gandara, et al.Pageof 23